Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link

Opportunity	Posted	Closing
Rural Health Care Services Outreach Program Agency: HRSA	09/29/20	12/01/20
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) Agency: NIH Institutions: NCINIDCR	09/28/20	01/07/24
Department of Defense HIV/AIDS Prevention Program Agency: AMRAA	09/24/20	09/23/22
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/23/20	12/14/21
Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/18/20	01/20/21
Comprehensive High-Impact HIV Prevention Programs for Community-Based Organizations Agency: NCHHSTP	09/17/20	11/20/20
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) Agency: NIH Institutions: NCIODP	09/15/20	01/18/22
Genomic Data Analysis Network: Genomic Data Center (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/04/20	11/12/20
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCIODP	09/04/20	09/07/23
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCIODP	09/04/20	09/07/23
Fiscal Year 2021 Consolidated Innovative Nuclear Research Agency: ID	09/03/20	02/11/21
Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNCINIEHSORWH	08/31/20	11/30/20
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/28/20	10/13/21
Glioblastoma Therapeutics Network (U19 Clinical Trial Required) Agency: NIH Institutions: NCI	08/27/20	11/19/20
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/26/20	01/04/21
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/26/20	01/04/21
NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/25/20	11/09/20
NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/25/20	11/09/20
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Agency: NIH Institutions: NCI	08/24/20	11/18/20
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/24/20	07/20/22
Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/20/20	10/30/20
Research to Improve Native American Health (R21 Clinical Trials Optional) Agency: NIH Institutions: NIDANIAAANIAMSNIDCRNIEHSNIMHNINRNIMHDNLMNCCIHNCATSNCIOBSSR	08/17/20	09/07/23
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANHLBINIAAANIAIDNIAMSNIBIBNIDCRNIEHSNIMHNINRNIMHDNLMNCIOBSSR	08/17/20	09/07/23
Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required) Agency: NIH Institutions: NCI	08/13/20	11/18/20
DoD Rare Cancers, Concept Award Agency: AMRAA	08/13/20	11/30/20
DoD Rare Cancers, Idea Development Award Agency: AMRAA	08/13/20	11/30/20
DoD Rare Cancers, Resource and Community Development Award Agency: AMRAA	08/13/20	11/30/20
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/13/20	05/04/23
Minority HIV Research Initiative (MARI) to Support Epidemiologic and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers Agency: HHSCDCERA	08/12/20	10/14/20
DoD Kidney Cancer, Clinical Research Nurse Development Award Agency: AMRAA	08/11/20	11/03/20
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/05/20	11/09/22
2020 Human Exploration Research Opportunities (HERO) Agency: JSC	07/31/20	07/30/21
Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional) Agency: NIH Institutions: NCINHGRI	07/30/20	07/08/21
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINIDDKNIEHSNCCIH	07/30/20	04/15/22
Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional) Agency: NIH Institutions: NHGRINCINEINHLBINIANIEHSNIMHNIMHDNINDSOBSSR	07/28/20	07/19/23
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional) Agency: NIH Institutions: NHGRINCINEINIANIEHSNIMHNINDSOBSSR	07/28/20	07/19/23
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional) Agency: NIH Institutions: NHGRIFICNCINIANIEHSNIMHOBSSR	07/28/20	07/19/23
Silicon-Carbide Ceramic Matrix Composite Cladding for Nuclear Fuels Agency: ID	07/28/20	10/22/20
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/23/20	11/06/20
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNIEHSNCIODPORWH	07/23/20	06/19/23
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNIEHSNCIODPORWH	07/23/20	06/19/23
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIDCR	07/22/20	09/07/22
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Agency: NIH Institutions: NCINHGRINIDCR	07/22/20	09/07/22
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIDCDNIMH	07/20/20	01/07/23
Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/16/20	12/16/20
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNIANIAAANIMHNCIOBSSR	07/15/20	06/19/23
PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	07/14/20	04/05/21
PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH	07/13/20	04/05/21
PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH	07/13/20	04/05/21
PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	07/13/20	04/05/21
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNLMNCCIHNCATS	07/10/20	04/05/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) Agency: NIH Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIEHSNIGMSNIMHNIMHDNINDSNLMNINRORIP	07/06/20	05/07/23
Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIA	07/02/20	02/17/21
DoD Pancreatic Cancer, Translational Research Partnership Award Agency: AMRAA	07/01/20	12/10/20
DoD Pancreatic Cancer, Idea Development Award Agency: AMRAA	07/01/20	12/10/20
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) Agency: NIH	06/30/20	05/07/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH	06/30/20	05/07/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH	06/29/20	05/07/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) Agency: NIH	06/29/20	08/08/23
Women’s Preventive Services Initiative Agency: HRSA	06/29/20	10/05/20
Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	06/29/20	11/19/20
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	06/25/20	11/09/20
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Agency: NIH	06/23/20	05/07/23
Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIDANCIODPOBSSR	06/16/20	10/19/20
Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINEINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIMHDFICNCCIHORIP	06/09/20	04/15/23
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) Agency: NIH Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR	06/03/20	03/17/23
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials) Agency: NIH Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR	06/03/20	03/17/23
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP	05/29/20	05/07/23
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Agency: NIH Institutions: NCCIHODS	05/20/20	05/07/23
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Agency: NIH Institutions: NCCIH	05/20/20	05/07/23
Metastasis Research Network (U54 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	05/13/20	05/28/21
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) Agency: NIH Institutions: NCCIHNCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDANIMHNINDSNIEHSNIMHD	05/12/20	05/07/23
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) Agency: NIH	05/12/20	05/07/23
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Agency: NIH Institutions: NEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHNCATSORIPNCI	05/08/20	05/07/23
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDANIEHSNINRNIMHDNLMNCCIHNCIICs	05/07/20	05/07/23
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIHNIDDKNIEHSNIMHNINDSNINRNIMHD	05/05/20	05/07/23
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPNCIICs	05/05/20	05/07/23
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) Agency: NIH Institutions: NCINEINIANIAAANICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNCCIH	05/05/20	05/07/23
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIHNICHDNIDANIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNLMORIPNIMHD	05/05/20	05/07/23
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNIANIDCDNIDANIMHNINRNIMHDNCCIHNCIOBSSR	04/30/20	09/07/23
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNIANIDCDNIDCRNCCIHNCI	04/30/20	09/07/23
DoD, Breast Cancer, Breakthrough Award Level 3 Agency: AMRAA	04/30/20	10/06/20
DoD, Breast Cancer, Innovator Award Agency: AMRAA	04/30/20	10/06/20
DoD, Breast Cancer, Breakthrough Award Level 4 Agency: AMRAA	04/30/20	10/06/20
DoD, Breast Cancer, Transformative Breast Cancer Consortium Award Agency: AMRAA	04/30/20	10/06/20
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). Agency: NIH Institutions: NIAID	04/24/20	10/09/20
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Agency: NIH Institutions: NIMHDNIANIDANCI	04/20/20	09/07/23
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/15/20	06/06/23
Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	04/14/20	06/24/21
Cyber-Physical Systems Agency: NSF	04/07/20	12/02/20
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNHLBINIANIAAANINDSNCI	04/03/20	07/14/22
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIBNIDCR	03/30/20	09/07/22
NIDA Small Research Grant Program (R03 Clinical Trial Required) Agency: NIH Institutions: NIDA	03/24/20	05/07/23
Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional) Agency: NIH Institutions: NIDA	03/24/20	08/13/21
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Agency: NIH Institutions: NCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHORIP	03/20/20	05/25/23
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/16/20	07/30/21
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/16/20	07/30/21
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/12/20	05/07/23
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) Agency: NIH Institutions: NIDDKNCI	03/11/20	06/08/21
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) Agency: NIH Institutions: NIDDKNCI	03/11/20	06/08/21
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) Agency: NIH Institutions: NCINCCIHNHGRINIAIDNICHDNIDDKNIEHSNIGMSNIMH	03/10/20	09/07/25
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	03/06/20	01/07/22
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) Agency: NIH Institutions: NIGMSNCINHLBINHGRINIANIAIDNIAMSNIDCRNIDDKNIDANIMHDNCCIHORWH	03/05/20	07/23/21
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/24/20	11/18/21
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC	02/03/20	07/28/22
Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC	02/03/20	07/28/22
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/27/20	05/07/23
Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNEINIMHNINDSNCI	01/23/20	05/26/22
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI	01/17/20	05/08/23
Biomedical Data Repository (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI	01/17/20	05/08/23
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/16/20	11/17/20
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/16/20	11/17/20
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	01/14/20	04/01/22
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	01/14/20	04/01/22
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/10/19	10/28/22
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	12/09/19	09/07/22
Co-infection and Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/22/19	01/07/23
Co-infection and Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/22/19	01/07/23
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	11/22/19	01/07/23
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/12/19	01/07/23
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	11/12/19	05/11/21
NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/08/19	01/07/23
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/04/19	09/25/22
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCI	10/18/19	11/07/22
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/18/19	01/07/23
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) Agency: NIH Institutions: FICNIAMSNIDDKNIMHNCI	10/18/19	12/03/20
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI	10/04/19	09/08/22
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI	10/04/19	09/08/22
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI	10/04/19	09/08/22
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI	10/04/19	09/08/22
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/02/19	01/07/23
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	10/02/19	01/07/23
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: OPPNETNEINIANIAAANIAMSNICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR	09/18/19	03/17/21
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) Agency: NIH Institutions: OPPNETNEINIANIAAANICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR	09/18/19	03/17/21
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: FICNIBIBNICHDNIDCDNIMHNINDSNCIOBSSRORWH	09/13/19	12/03/20
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNHLBINIDCRNCI	09/12/19	01/07/23
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) Agency: NIH Institutions: NHLBINCINIANIAID	09/09/19	01/14/22
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANIAAA	09/09/19	09/07/21
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/06/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/05/19	05/07/21
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	09/03/19	01/10/22
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	09/03/19	01/10/22
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/29/19	03/11/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	07/16/22
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/28/19	05/27/22
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/28/19	05/27/22
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	08/16/19	07/16/22
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	08/16/19	09/07/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/30/19	02/11/22
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) Agency: NIH Institutions: NCI	07/26/19	10/30/20
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINHLBINIAAANIDANIEHSCTP	07/08/19	03/08/21
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/19	09/07/22
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/22/19	11/15/21
Postdoctoral Research Associate Training (PRAT) Program (Fi2) Agency: NIH Institutions: NIGMS	05/21/19	10/04/21
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Agency: NIH Institutions: FICNCINIDANIMH	05/14/19	08/20/21
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/13/19	11/15/20
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/13/19	11/15/20
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/08/19	10/08/21
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH	05/08/19	05/07/22
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/01/19	12/10/21
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIEHS	04/11/19	11/08/21
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIEHS	04/11/19	11/08/21
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/08/19	06/17/21
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/13/19	10/18/20
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/27/19	11/08/21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/27/19	11/08/21
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Biology of Bladder Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Biology of Bladder Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) Agency: NIH Institutions: NIDANIMHDNIMHNCINCCIHORWH	01/09/19	09/07/21
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) Agency: NIH Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH	01/09/19	09/07/21
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA	01/08/19	01/07/22
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/08/19	01/07/22
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIAMS	01/08/19	01/07/22
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	01/08/19	01/07/22
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Agency: NIH Institutions: NIBIBNCINIANIAAANINDS	01/08/19	05/07/21
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) Agency: NIH Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH	12/21/18	01/07/21
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	12/21/18	01/07/22
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) Agency: NIH Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI	12/21/18	01/07/22
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR	12/21/18	01/07/22
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	12/11/18	11/04/20
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCIOBSSR	11/28/18	03/04/21
Emerging Global Leader Award (K43 Independent Clinical Trial Required) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	11/02/18	11/04/20
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS	10/24/18	09/05/21
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS	10/24/18	09/05/21
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIHNCATSNHLBIORIPNICHD	10/17/18	02/02/21
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	10/05/18	03/04/21
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	10/05/18	03/04/21
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH	10/05/18	04/15/21
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH	10/05/18	12/11/20
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINCCIHOBSSR	10/01/18	01/07/22
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINCCIHOBSSR	10/01/18	01/07/22
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR	10/01/18	01/07/22
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR	10/01/18	01/07/22
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/28/18	07/11/21
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD	09/21/18	01/07/22
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIDANCINCCIHNIAAANICHD	09/10/18	09/07/21
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/07/18	08/11/21
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/05/18	11/13/20
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINCCIHODS	08/14/18	09/07/21
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/07/18	09/07/21
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/07/18	09/07/21
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIAMSNIDAODS	07/25/18	09/07/21
Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIMHD	07/25/18	09/07/21
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/24/18	03/08/21
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNCCIH	07/17/18	09/07/21
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNINR	07/17/18	09/07/21
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINICHDODPOBSSR	07/12/18	09/10/21
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/25/21
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/25/21
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/15/21
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/15/21
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/18	06/14/21
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS	06/20/18	09/04/21
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNCINEI	06/14/18	06/03/21
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIBIBNCI	05/16/18	09/07/21
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/30/18	01/11/21
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Agency: NIH Institutions: NIAIDNCINIMH	04/20/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/29/18	11/19/20
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD	03/28/18	05/07/21
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH	03/28/18	05/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIAAANIDCRNIDANINR	03/06/18	04/05/21
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	02/13/18	02/08/21
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/13/18	02/18/21
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/26/18	01/25/21
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) Agency: NIH Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP	01/25/18	09/07/21
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIBIB	12/21/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINCCIH	12/15/17	01/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/06/17	03/12/21
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Agency: NIH Institutions: NCI	12/06/17	03/12/21
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Research Experiences (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Courses for Skills Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/30/17	11/13/20
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR	11/29/17	01/07/21
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Agency: NIH Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR	11/29/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) Agency: NIH Institutions: NCI	11/20/17	05/07/21
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI	11/20/17	05/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	05/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	05/07/21
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNIANIDDKNIDANIDCRNINDSNCCIHNIMHDNCI	11/07/17	05/07/21
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCININRNIANIDANIDCRNINDSNCCIHNIMHD	11/07/17	05/07/21
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials) Agency: NIH Institutions: NCI	10/31/17	05/07/21
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required) Agency: NIH Institutions: NCI	10/31/17	05/07/21
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH	10/17/17	01/07/21
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) Agency: NIH Institutions: NCINIDCR	10/12/17	01/07/21
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed Agency: NIH Institutions: NCI	10/12/17	10/08/20
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	10/12/17	10/08/20
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDANCCIH	10/10/17	01/07/21
Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	10/03/17	01/07/21
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/29/17	01/07/21
Biology of Lung, and Head and Neck Preneoplasias (R21) Agency: NIH Institutions: NCI	08/16/17	01/07/21
Biology of Lung, and Head and Neck Preneoplasias (R01) Agency: NIH Institutions: NCI	08/15/17	01/07/21
Fundamental Research to Counter Weapons of Mass Destruction Agency: DTRA	03/20/15	09/30/24

TOP